Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
AAVantgarde Bioaavantgarde.com · Low evidenceAAVantgarde is a biotechnology company pioneering next-generation therapies for inherited retinal disorders caused by large gene mutations, specifically Stargardt disease and Usher 1B syndrome. The company's technology enables the delivery of large genes like ABCA4 to address the genetic root cause of these conditions.
Parse Score